Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 29;18(7):3520.
doi: 10.3390/ijerph18073520.

The Role of Heme Oxygenase-1 Promoter Polymorphisms in Perinatal Disease

Ruka Nakasone  1 , Mariko Ashina  1 , Shinya Abe  1 , Kenji Tanimura  2 , Hans Van Rostenberghe  3 , Kazumichi Fujioka  1
Affiliations

The Role of Heme Oxygenase-1 Promoter Polymorphisms in Perinatal Disease

Ruka Nakasone et al. Int J Environ Res Public Health. .

Abstract

Heme oxygenase (HO) is the rate-limiting enzyme in the heme catabolic pathway, which degrades heme into equimolar amounts of carbon monoxide, free iron, and biliverdin. Its inducible isoform, HO-1, has multiple protective functions, including immune modulation and pregnancy maintenance, showing dynamic alteration during perinatal periods. As its contribution to the development of perinatal complications is speculated, two functional polymorphisms of the HMOX1 gene, (GT)n repeat polymorphism (rs3074372) and A(-413)T single nucleotide polymorphism (SNP) (rs2071746), were studied for their association with perinatal diseases. We systematically reviewed published evidence on HMOX1 polymorphisms in perinatal diseases and clarified their possible significant contribution to neonatal jaundice development, presumably due to their direct effect of inducing HO enzymatic activity in the bilirubin-producing pathway. However, the role of these polymorphisms seems limited for other perinatal complications such as bronchopulmonary dysplasia. We speculate that this is because the antioxidant or anti-inflammatory effect is not directly mediated by HO but by its byproducts, resulting in a milder effect. For better understanding, subtyping each morbidity by the level of exposure to causative environmental factors, simultaneous analysis of both polymorphisms, and the unified definition of short and long alleles in (GT)n repeats based on transcriptional capacity should be further investigated.

Keywords: (GT)n repeat; SNPs; genetics; heme oxygenase-1; neonatal jaundice; perinatal diseases; polymorphism.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Poggi C., Giusti B., Vestri A., Pasquini E., Abbate R., Dani C. Genetic polymorphisms of antioxidant enzymes in preterm infants. J. Mater. Fetal Neon. Med. Off. J. Eur. Assoc. Perin. Med. Federat. Asia Ocean. Perin. Soc. Int. Soc. Perin. Obstet. 2012;25(Suppl. 4):131–134. doi: 10.3109/14767058.2012.714976. - DOI - PubMed
    1. Tenhunen R., Marver H.S., Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. USA. 1968;61:748–755. doi: 10.1073/pnas.61.2.748. - DOI - PMC - PubMed
    1. Maines M.D. Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 1988;2:2557–2568. doi: 10.1096/fasebj.2.10.3290025. - DOI - PubMed
    1. Exner M., Minar E., Wagner O., Schillinger M. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Rad. Biol. Med. 2004;37:1097–1104. doi: 10.1016/j.freeradbiomed.2004.07.008. - DOI - PubMed
    1. Fredenburgh L.E., Perrella M.A., Mitsialis S.A. The role of heme oxygenase-1 in pulmonary disease. Am. J. Respir. Cell Mol. Biol. 2007;36:158–165. doi: 10.1165/rcmb.2006-0331TR. - DOI - PMC - PubMed

Publication types

Substances

LinkOut - more resources